Cleopatra Hospitals Group SAE 2020 AR2
The report outlines Cleopatra Hospitals Group's operational and financial performance for 2020, highlighting its resilience during the COVID-19 pandemic. The Group achieved an 11% revenue growth to EGP 2.0 billion, driven by recovering volumes and an optimized service mix. Key developments included the conversion of Queens and El Katib hospitals into COVID-19 isolation facilities, the acquisition of a majority stake in Bedaya IVF center, and the formation of a joint venture for healthcare facility management. Additionally, the Group advanced its digital transformation by rolling out the Clinisys HIS/ERP system across multiple facilities.
Company: Cleopatra Hospitals Group SAE
Sector: Health Care
Country: Egypt
Year: 2020
Type: AR2
Pages: 82
Cleopatra Hospitals Group SAE
Annual Report
The report outlines Cleopatra Hospitals Group's operational and financial performance for 2020, highlighting its resilience during the COVID-19 pandemic. The Group achieved an 11% revenue growth to EGP 2.0 billion, driven by recovering volumes and an optimized service mix. Key developments included the conversion of Queens and El Katib hospitals into COVID-19 isolation facilities, the acquisition of a majority stake in Bedaya IVF center, and the formation of a joint venture for healthcare facility management. Additionally, the Group advanced its digital transformation by rolling out the Clinisys HIS/ERP system across multiple facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women in Management
Employees